Bowman-birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 24, 2008, Pages 11707-11717

  Dia, Vermont P ^a   Berhow, Mark A ^b   De Mejia, Elvira Gonzalez ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Antagonistic interaction; Inflammation; Isobolographic analysis; NO iNOS; PGE2 COX 2; Soybean bioactive compounds; Synergistic interaction

Indexed keywords

GLYCINE MAX; MAMMALIA;

ANTIINFLAMMATORY AGENT; BOWMAN BIRK INHIBITOR; GENISTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PLANT EXTRACT; PROSTAGLANDIN E2;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; SOYBEAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; DINOPROSTONE; GENISTEIN; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; PLANT EXTRACTS; SIGNAL TRANSDUCTION; SOYBEANS; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

EID: 58849087675     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf802475z     Document Type: Article

References (65)

1. Omono, A. O.; Aluko, R. E. Soybean foods and their benefits: Potential mechanism of action. Nutr. Rev. 2005, 63, 272-283.
2. Tikkanen, M. J.; Adlercreutz, H. Dietary soy-derived isoflavone phytoestrogens. Biochem. Pharmacol. 2000, 60, 1-5.
3. Kallig, S. E.; Honig, D. M.; Metzler, M. Oxidative metabolism of the soy isoflavone daidzein and genistein in human in vitro and in vivo. J. Agric. Food Chem. 2001, 49, 3024-3033.
4. Messina, M.; Flickinger, B. Hypothesized anticancer effect of soy: evidence points to isoflavones as the primary anticarcinogens. Pharm. Biol. 2002, 40, S6-S23.
5. Mota, M.; Garvagu, S.; Popa, S.; Schiopu, S.; Panduru, N. M.; Mota, E. Soya-the medicine food product. Rom. J. Int. Med. 2007, 45, 113-121.
6. Lamartiniere, C. A.; Cotroneo, M. S.; Fritz, W. A.; Wang, J.; Mentor-Marcel, R.; Elgavish, A. Genistein chemoprevention: Timing and mechanism of action in murine mammary and prostate. J. Nutr. 2002, 132, 552S-558S.
7. Cohen, L. A.; Zhao, Z.; Pittman, B.; Scinea, J. A. Effect of intact and isoflavone-depleted soy protein in NMU-induced rat mammary tumorigenesis. Carcinogenesis 2002, 21, 929-935.
8. Isanga, J.; Zhang, G. Soybean bioactive components and their implications to health - A review. Food Rev. Int. 2008, 24, 252-276.
9. Berhow, M. A.; Cantrell, C. L.; Duval, S. M.; Dobbies, T. A.; Maynes, J.; Vaughn, S. F. Analysis and quantitative determination of group B saponins in processed soybean products. Phytochem. Anal. 2002, 13, 343-348.
10. Shi, J.; Arunasalam, K.; Yenny, D.; Kakuda, Y.; Mittal, G.; Jiang, Y. Saponin from edible legumes: Chemistry, processing and health benefits. J. Med. Food 2004, 7, 67-68.
11. Rockfort, S.; Panozzo, J. Phytochemicals for health, the role of pulses. J. Agric. Food Chem. 2007, 55, 7981-7994.
12. Wang, W.; Dia, V. P.; Vasconez, M.; Nelson, R.; Gonzalez-de Mejia, E. Analysis of soybean derived-peptides and the effect of cultivar, environmental conditions and processing on lunasin concentration in soybean and soy products. J. AOAC Int. 2008, 91 (4), 936-946.
13. Wang, W.; de Mejia, E. G. A new frontier in soy bioactive peptides that may prevent age-related chronic diseases. Compr. Rev. Food Sci. Food Saf. 2005, 14, 63-78.
14. Mackey, R.; Ekangaki, A.; Eden, J. A. The effect of soy protein in women and men with elevated plasma lipids. Biofactors 2000, 12, 251-257.
15. Nagaoka, S.; Miwa, K.; Eto, M.; Kuzuya, Y.; Hori, G.; Yamamoto, K. Soy peptide hydrolyzate with bound phospholipids decreases micellar solubility and cholesterol absorption in rats and Caco-2 cells. J. Nutr. 1999, 129, 1725-1730.
16. Vaughn, N.; Rizzo, A.; Doane, D.; Beverly, J.; Gonzalez-de Mejia, E. Intracerebroventricular administration of soy protein hydrolysates reduces body weight without affecting food intake in rats. Plant Foods Hum. Nutr. 2008, 63, 41-46.
17. de Lumen, B. O. Lunasin: A cancer preventive peptide. Nutr. Rev. 2005, 63, 16-21.
18. Malikarjun-Gouda, K. G.; Gowda, L. R.; Appu Rao, A. G.; Prakash, V. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J. Agric. Food Chem. 2006, 54, 4568-4573.
19. Tsuruki, T.; Kishi, K.; Takahashi, M.; Tanaka, M.; Matsukawa, T.; Yoshikawa, M. Soymetide, an immunostimulating peptide derived from soybean β-conglycinin, is an fMLP agonist. FEBS Lett. 2003, 540, 206-210.
20. Aggarwal, B. B.; Shishodia, S.; Sandur, S. K.; Pandey, M. K.; Sethi, G. Inflammation and cancer: How hot is the link? Biochem. Pharmacol. 2006, 72, 1605-1621.
21. Libby, P. Inflammatory mechanisms: The molecular basis of inflammation and disease. Nutr. Rev. 2007, 65, S140-S146.
22. Jackson, L.; Evers, B. M. Chronic inflammation and pathogenesis of gastrointestinal and pancreatic cancers. Cancer Treat. Res. 2006, 130, 39-65.
23. Schottenfeld, D.; Beebe-Dimmer, J. Chronic inflammation: A common and important factor in the pathogenesis of neoplasia. Ca - Cancer J. Clin. 2006, 56, 69-83.
24. Itzkowitz, S. H.; Yio, X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol.: Gastrointest. Liver Physiol. 2004, 287, G7-G17.
25. Nelson, W. G.; De Marco, A. M.; De Weese, T. L.; Isaacs, W. B. The role of inflammation on the pathogenesis of prostate cancer. J. Urol. 2004, 172, S6-S11.
26. O'Bryne, K. J.; Dalgleish, A. G. Chronic immune activation and inflammation as the cause of malignancy. Br. J. Cancer 2001, 84, 473-485.
27. Whitcomb, D. C. Inflammation and cancer V. Chronic pancreatitis and pancreatic cancer. Am. J. Physiol.: Gastrointest. Liver Physiol. 2004, 287, G315-G319.
28. Nordin, A.; Abastado, J. P. Macrophages and cancer. Front. Biosci. 2008, 13, 3494-3505.
29. Guha, M.; Mackman, N. Lipopolysaccharide induction of gene expression in human monocytes. Cell. Signalling 2001, 13, 85-94.
30. Sharma, J. N.; Al-Omran, A.; Parvathy, S. S. Role of nitric oxide in inflammatory bowel disease. Inflammapharmacology 2006, 15, 252-259.
31. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992, 6, 3051-3064.
32. Seril, D. N.; Liao, J.; Yang, G. Y.; Yang, C. S. Oxidative stress and ulcerative colitis-associated carcinogenesis: studied in humans and animal models. Carcinogenesis 2003, 24, 353-362.
33. Howe, L. R. Inflammation and breast cancer. Cyclooxygenase signaling and breast cancer. Breast Cancer Res. 2007, 9, 210.
34. Mann, J. R.; Dubois, R. N. Cyclooxygenase-2 and gastrointestinal cancer. Cancer J. 2004, 10, 145-152.
35. Furstenberger, G.; Gross, M.; Marks, F. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: Role of prostaglandin E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). Carcinogenesis 1989, 10, 91-96.
36. 2 in bile acid-caused promotion of colon carcinogenesis and antipromotion by the cyclooxygenase inhibitor indomethacin. Jpn. J. Cancer Res. 1987, 78, 791-798.
37. Berhow, M. A. Modern analytical techniques for flavonoid determination. In Flavonoids in the Living Cell; Buslig, B. S., Manthey, J. A., Eds.; Kluwer Academic/Plenum Publishers: New York, 2002; Vol. 505, pp 61-76.
38. Berhow, M. A.; Kong, S. B.; Duval, S. M. Complete quantification of group A and group B saponins in soybeans. J. Agric. Food Chem. 2006, 54, 2035-2044.
39. Wang, W.; Bringe, N. A.; Berhow, M. A.; Gonzalez de Mejia, E. β-Conglycinins among sources of bioactives in hydrolysates of different soybean varieties that inhibit leukemia cells in vitro. J. Agric. Food Chem. 2008, 56, 4012-4020.
40. Dia, V. P.; Wang, W.; Oh, V. L.; de Lumen, B. O.; Gonzalez de Mejia, E. Isolation, purification and characterization of lunasin from defatted soybean flour and in vitro evaluation of its anti-inflammatory activity. Food Chem. 2008, DOI: 10.1016/j.foodchem.2008.09.023.
41. Gessner, P. K. Isobolographic analysis of interactions: An update on applications and utility. Toxicology 1995, 105, 161-179.
42. Hori, M.; Kita, M.; Torihashi, S.; Miayamot, S.; Won, K. J.; Sato, K.; Ozaki, H.; Karaki, H. Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. Am. J. Physiol.: Gastrointest. Liver Physiol. 2001, 280, G920-G938.
43. Robbins, R. A.; Khaled, H.; Nelson, D.; Sato, E.; Hoyt, J. C. Nitric oxide, peroxynitrite, and lower respiratory tract inflammation. Immunopharmacology 2000, 28, 217-221.
44. Graziewicz, M.; Wink, D. A.; Laval, F. Nitric oxide inhibits DNA ligase activity: Potential mechanism for NO-mediated DNA damage. Carcinogenesis 1996, 17, 2501-2505.
45. Williams, C. S.; Mann, M.; DuBois, R. N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999, 18, 7908-7916.
46. Dannenberg, A. J.; Altorki, N. K.; Boyle, J. O.; Dang, C.; Howe, L. R; Weksler, B. B.; Subbaramiah, K. Cyclooxygenase 2: A pharmacological target for the prevention of cancer. Lancet Oncol. 2001, 2, 544-551.
47. 2 and luekotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986, 91, 837-844.
48. Shacter, E.; Weitzman, S. A. Chronic inflammation and cancer. Oncology (Hunting) 2002, 16, 217-226.
49. Chan, G.; Boyle, J. O.; Yang, E. K. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 1991, 59, 991-994.
50. Kao, T. H.; Wu, W. M.; Hung, C. F.; Wu, W. B.; Chen, B. H. Anti-inflammatory effects of soybean powder produced from soybean cake. J. Agric. Food Chem. 2007, 55, 11068-11079.
51. Chacko, B. K.; Chandler, R. T.; D'Alessandro, T. L.; Mundhekar, A.; Khoo, N. K. H.; Botting, N.; Barnes, S.; Patel, R. P. Antiinflammatory effects of isoflavones are dependent on flow and human endothelial cell PPARγ. Biochem. Mol. Genet. Mech. 2007, 137, 351-356.
52. Mezei, O.; BAnz, W. J.; Steger, R. W.; Peluso, M. R.; Winters, T. A.; Shay, N. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J. Nutr. 2003, 133, 1238-1243.
53. Wang, X.; Chen, S.; Ma, G.; Ye, M.; Lu, G. Genistein protects dopaminergic neurons by inhibiting microglial activation. Neuroreport 2005, 16, 267-270.
54. Kim, H. Y.; Yu, R.; Kim, J. S.; Kim, Y. K.; Sung, M. K. Antiproliferative crude soy saponin extract modulates the expression of IκBÜ, protein kinase C, and cyclooxygenase-2 in human colon cancer cells. Cancer Lett. 2004, 210, 1-6.
55. Larsen, C. G.; Anderson, A. O.; Oppenehim, J. J.; Matsushima, K. Production of interleukin-8 human dermal fibrobalsts and keratinocytes in response to interleukin-1 or tumor necrosis factor. Immunology 1989, 68, 31-36.
56. Baggiolini, M.; Dewald, B.; Moser, B. Interleukin-8 and related chemotactic cytokines - XCX CC chemokines. Adv. Immunol. 1994, 55, 97-119.
57. Ware, J. H.; Wan, X. S.; Newberne, P.; Kennedy, A. R. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis. Dig. Dis. Sci. 1999, 44, 986-990.
58. Kennedy, A. R. The Bowman-Birk inhibitor from soybeans as anticarcinogenic agent. Am. J. Clin. Nutr. 1997, 68, 1206S-1412S.
59. Larionova, N. I.; Gladysheva, I. P.; Tikhonova, T. V.; Kazankaya, N. F. Inhibition of cathepsin G and human granulocyte elastase by multiple forms of Bowman-Birk type soybean inhibitor. Biokhimiya (Moscow) 1993, 58, 1437-44 (in Russian).
60. Ware, J. H.; Wan, X. S.; Rubin, H.; Schechter, N. M.; Kennedy, A. R. Soybean Bowman-Birk inhibitor is a highly effective inhibitor of human mast cell chymase. Arch. Biochem. Biophys. 1997, 344, 133-138.
61. Si, H.; Liu, D. Phytochemical genistein in the regulation of vascular functions: New insights. Curr. Med. Chem. 2007, 14, 2581-2589.
62. L downregulation, and Cdc2 kinase activity. Nutr. Cancer 2003, 45, 113-123.
63. 2 and tumor necrosis factor-R in RAW 264.7 murine macrophages. Biosci., Biotechnol., Biochem. 2003, 67, 1056-1062.
64. Hooshmand, S.; Soung, D. Y.; Lucas, E. A.; Madihally, S. V.; Levenson, C. W.; Arjmandi, B. H. Genistein reduces the production of proinflammatory molecules in human chondrocytes. J. Nutr. Biochem. 2007, 18, 609-614.
65. Voss, R. H.; Ermler, U.; Essen, L. O.; Wenzl, G.; Kim, Y. M.; Flecker, P. Crystal structure of the bifuncional soybean Bowman-Birk inhibitor at 0.28 nm resolution. Structural peculiarities in a folded protein conformation. Eur. J. Biochem. 1996, 242, 122-131.